Skip to content
← Back to this collection

PUBLICATIONS · 36170501

GPRC5D-Targeted CAR T Cells for Myeloma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2022 Sep 29
First author
Mailankody S

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2022 Dec;19(12):747. doi: 10.1038/s41571-022-00701-6.
    note
    Source null
    related pmid
    36253450
    relationship
    Comment in
  2. citation
    N Engl J Med. 2022 Dec 15;387(24):2295-2296. doi: 10.1056/NEJMc2213985.
    note
    Source null
    related pmid
    36516097
    relationship
    Comment in
  3. citation
    N Engl J Med. 2022 Dec 15;387(24):2296. doi: 10.1056/NEJMc2213985.
    note
    Source null
    related pmid
    36516098
    relationship
    Comment in

Authors and identifiers

  1. name
    Mailankody S
    type
    Author
  2. name
    Devlin SM
    type
    Author
  3. name
    Landa J
    type
    Author
  4. name
    Nath K
    type
    Author
  5. name
    Diamonte C
    type
    Author
  6. name
    Carstens EJ
    type
    Author
  7. name
    Russo D
    type
    Author
  8. name
    Auclair R
    type
    Author
  9. name
    Fitzgerald L
    type
    Author
  10. name
    Cadzin B
    type
    Author
  11. name
    Wang X
    type
    Author
  12. name
    Sikder D
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Mailankody S
    type
    Author
  2. name
    Devlin SM
    type
    Author
  3. name
    Landa J
    type
    Author
  4. name
    Nath K
    type
    Author
  5. name
    Diamonte C
    type
    Author
  6. name
    Carstens EJ
    type
    Author
  7. name
    Russo D
    type
    Author
  8. name
    Auclair R
    type
    Author
  9. name
    Fitzgerald L
    type
    Author
  10. name
    Cadzin B
    type
    Author
  11. name
    Wang X
    type
    Author
  12. name
    Sikder D
    type
    Author
bibliography ids
  1. nci-bib-ec9bd635e8f44aa72a495f42
book metadata
content sha256
d626c138c7e2bb67e280773262ea26f43da4195b1ca3d0620ba8d12afd553f95
document type
citation
dois
  1. 10.1056/NEJMoa2209900
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:36170501
immutable id
pubmed:36170501@d626c138c7e2bb67e280773262ea26f43da4195b1ca3d0620ba8d12afd553f95
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
13
name
The New England journal of medicine
nlm unique id
0255562
pages
1196-1206
volume
387
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2022 Dec;19(12):747. doi: 10.1038/s41571-022-00701-6.
    note
    Source null
    related pmid
    36253450
    relationship
    Comment in
  2. citation
    N Engl J Med. 2022 Dec 15;387(24):2295-2296. doi: 10.1056/NEJMc2213985.
    note
    Source null
    related pmid
    36516097
    relationship
    Comment in
  3. citation
    N Engl J Med. 2022 Dec 15;387(24):2296. doi: 10.1056/NEJMc2213985.
    note
    Source null
    related pmid
    36516098
    relationship
    Comment in
outcomes validated
false
pmid
36170501
provenance
batch id
d370e99271168e8a8a13
provider
NCBI PubMed ESummary
record sha256
71867921fcbcd80f71aeba051758ee89e2923dc85b921b38d3e73ac930dad07e
response sha256
f65ace3ceb1efa86f3fbab8e01ce265243e7c6b7f13c5f71c357c1f219ad79c4
retrieved at
2026-09-09T23:48:13.005737+00:00
publication date
display
2022 Sep 29
precision
day
year
2022
publication types
  1. Clinical Trial, Phase I
  2. Journal Article
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/36170501/
title
GPRC5D-Targeted CAR T Cells for Myeloma.

Preserved source evidence · Not medical advice